The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease

Journal of the American College of Cardiology

Volumn 68, Issue 17, 2016, Pages 1898-1907

  Jones, W Schuyler ^a   Roe, Matthew T ^a   Antman, Elliott M ^b   Pletcher, Mark J ^c   Harrington, Robert A ^d   Rothman, Russell L ^e   Oetgen, William J ^f   Rao, Sunil V ^a   Krucoff, Mitchell W ^a   Curtis, Lesley H ^a   Hernandez, Adrian F ^a   Masoudi, Frederick A ^g  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

aspirin; coronary artery disease; Patient Centered Outcomes Research Institute; pragmatic clinical trial

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL STUDY; COST BENEFIT ANALYSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; INFORMED CONSENT; MEDICARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REVIEW; UNITED STATES; CARDIOVASCULAR DISEASES; PROCEDURES; STANDARDS;

CARDIOVASCULAR DISEASES; HUMANS; PRAGMATIC CLINICAL TRIALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; UNITED STATES;

EID: 84993960679     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.07.781     Document Type: Review

References (43)

1. 1 ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986), 57–66.
2. 2 ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988), 349–360.
3. 3 GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993), 673–682.
4. 4 SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. [erratum in N Engl J Med 1992;327:1768] N Engl J Med 327 (1992), 685–691.
5. 5 Moss, A.J., Zareba, W., Hall, W.J., et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002), 877–883.
6. 6 Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002), 7–22.
7. 7 Tricoci, P., Allen, J.M., Kramer, J.M., et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301 (2009), 831–841.
8. 8 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. for the American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
9. 9 Fuster, V., Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. J Am Coll Cardiol 64 (2014), 520–522.
10. 10 James, S., Rao, S.V., Granger, C.B., Registry-based randomized clinical trials—a new clinical trial paradigm. Nat Rev Cardiol 12 (2015), 312–316.
11. 11 Rooke, T.W., Hirsch, A.T., Misra, S., et al. 2011 ACCF/AHA focused update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 58 (2011), 2020–2045.
12. 12 Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
13. 13 Fihn, S.D., Blankenship, J.C., Alexander, K.P., et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 64 (2014), 1929–1949.
14. 14 Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (2014), e139–e228.
15. 15 January, C.T., Wann, L.S., Alpert, J.S., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64 (2014), e1–e76.
16. 16 Antman, E.M., Harrington, R.A., Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. JAMA 308 (2012), 1743–1744.
17. 17 Eapen, Z.J., Lauer, M.S., Temple, R.J., The imperative of overcoming barriers to the conduct of large, simple trials. JAMA 311 (2014), 1397–1398.
18. 18 Eapen, Z.J., Vavalle, J.P., Granger, C.B., et al. Rescuing clinical trials in the United States and beyond: a call for action. Am Heart J 165 (2013), 837–847.
19. 19 Kim, E.S., Carrigan, T.P., Menon, V., International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 58 (2011), 671–676.
20. 20 Sherman, R.B., Woodcock, J., Norden, J., et al. New FDA regulation to improve safety reporting in clinical trials. N Engl J Med 365 (2011), 3–5.
21. 21 Krucoff, M.W., Brindis, R.G., Hodgson, P.K., et al. Medical device innovation: prospective solutions for an ecosystem in crisis: adding a professional society perspective. J Am Coll Cardiol Intv 5 (2012), 790–796.
22. 22 Califf, R.M., Harrington, R.A., American industry and the U.S. Cardiovascular Clinical Research Enterprise: an appropriate analogy?. J Am Coll Cardiol 58 (2011), 677–680.
23. 23 Roe, M.T., Mahaffey, K.W., Ezekowitz, J.A., et al. The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations. Am Heart J 169 (2015), 743–750.
24. 24 Federal Policy for the Protection of Human Subjects. Fed Regist 80 (2015), 53931–54061.
25. 25 Lauer, M.S., D'Agostino, R.B. Sr., The randomized registry trial—the next disruptive technology in clinical research?. N Engl J Med 369 (2013), 1579–1581.
26. 26 Fröbert, O., Lagerqvist, B., Olivecrona, G.K., et al., for the TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369 (2013), 1587–1597.
27. 27 Rao, S.V., Hess, C.N., Barham, B., et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. J Am Coll Cardiol Intv 7 (2014), 857–867.
28. 28 Hess, C.N., Rao, S.V., Kong, D.F., et al. Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). Am Heart J 166 (2013), 421–428.
29. 29 Hambraeus, K., Held, C., Johansson, P., et al. Annual report SWEDEHEART 2012. Scand Cardiovasc J 48:Suppl 63 (2014), 2–133.
30. 30 Jackson, N., Atar, D., Borentain, M., et al. Improving clinical trials for cardiovascular diseases: a position paper for the Cardiovascular Round Table of the European Society of Cardiology. Eur Heart J 37 (2016), 747–754.
31. 31 Department of Health and Human Services. Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-15-004.html. Accessed August 9, 2016.
32. 32 Department of Health and Human Services. Clinical and Translational Science Award (CTSA) Trial Innovation Centers. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-15-002.html. Accessed August 9, 2016.
33. 33 National Institutes of Health. NIH Collaboratory. Available at: https://www.nihcollaboratory.org/Pages/default.aspx. Accessed August 9, 2016.
34. 34 Fiore, L.D., Lavori, P.W., Integrating randomized comparative effectiveness research with patient care. N Engl J Med 374 (2016), 2152–2158.
35. 35 Patient-Centered Outcomes Research Institute. PCORnet: The National Patient-Centered Clinical Research Network. Available at: http://pcornet.org. Accessed August 9, 2016.
36. 36 Hernandez, A.F., Fleurence, R.L., Rothman, R.L., The ADAPTABLE trial and PCORnet: shining light on a new research paradigm. Ann Intern Med 163 (2015), 635–636.
37. 37 PCORnet. ADAPTABLE, the Aspirin Study. Available at: http://www.theaspirinstudy.com. Accessed August 9, 2016.
38. 38 Duke University. Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE). Available at: https://clinicaltrials.gov/ct2/show/NCT02697916. Accessed August 9, 2016.
39. 39 Hlatky, M.A., Ray, R.M., Burwen, D.R., et al. Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes 7 (2014), 157–162.
40. 40 Psaty, B.M., Delaney, J.A., Arnold, A.M., et al. The study of cardiovascular health outcomes in the era of claims data: the Cardiovascular Health Study. Circulation 133 (2016), 156–164.
41. 41 Mentz, R.J., Newby, L.K., Neely, B., et al. Assessment of administrative data to identify acute myocardial infarction in electronic health records. J Am Coll Cardiol 67 (2016), 2441–2442.
42. 42 Mahaffey, K.W., Wojdyla, D.M., Carroll, K., et al., for the PLATO Investigators. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 124 (2011), 544–554.
43. 43 Xian, Y., Wang, T.Y., McCoy, L.A., et al. Association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study. Circulation 132 (2015), 174–181.